Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Narnatumab |
| Synonyms | |
| Therapy Description |
Narnatumab (IMC-RON8) is a monoclonal antibody directed against RON, which potentially results in decreased proliferation of RON-expressing tumor cells (PMID: 28161886). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Narnatumab | IMC-RON8|LY3012219 | Narnatumab (IMC-RON8) is a monoclonal antibody directed against RON, which potentially results in decreased proliferation of RON-expressing tumor cells (PMID: 28161886). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|